These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27383396)

  • 21. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
    Chen H; Werner S; Tao S; Zörnig I; Brenner H
    Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
    Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
    Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A specific autoantibody against a novel tumour-association antigen derived from human DNA-topoiomerase I is a potential biomarker for early diagnosis and favourable prognosis in patients with colorectal carcinoma.
    Zhao F; Cao M; Jiang XH; Xie K; Ye SR; Yie SM
    Biomarkers; 2020 Mar; 25(2):149-156. PubMed ID: 31922440
    [No Abstract]   [Full Text] [Related]  

  • 26. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer.
    Huangfu M; Xu S; Li S; Sun B; Lee KH; Liu L; Sun S
    Tumour Biol; 2016 Jul; 37(7):8709-14. PubMed ID: 26738866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
    Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA
    Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
    Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
    Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
    Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer.
    Chen JS; Kuo YB; Chou YP; Chan CC; Fan CW; Chen KT; Huang YS; Chan EC
    Clin Chim Acta; 2011 Jul; 412(15-16):1417-22. PubMed ID: 21536019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer.
    Teras LR; Gapstur SM; Maliniak ML; Jacobs EJ; Gansler T; Michel A; Pawlita M; Waterboer T; Campbell PT
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):219-223. PubMed ID: 29254936
    [No Abstract]   [Full Text] [Related]  

  • 32. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
    Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
    Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.
    Werner S; Chen H; Butt J; Michel A; Knebel P; Holleczek B; Zörnig I; Eichmüller SB; Jäger D; Pawlita M; Waterboer T; Brenner H
    Sci Rep; 2016 May; 6():25467. PubMed ID: 27140836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
    Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
    Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control study.
    Chao S; Ying J; Liew G; Marshall W; Liew CC; Burakoff R
    J Exp Clin Cancer Res; 2013 Jul; 32(1):44. PubMed ID: 23876008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel algorithm to improve specificity in ovarian cancer detection.
    Arjomandi A; Delanoy ML; Walker RP; Binder SR
    Cancer Treat Res Commun; 2018; 15():32-35. PubMed ID: 30207285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.
    Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L
    Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.